Anthera Pharmaceuticals, Inc.
ANTH · OTC
3/31/2018 | 12/31/2017 | 9/30/2017 | 6/30/2017 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $8,086 | $2,196 | $6,076 | $11,151 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $653 | $995 | $1,771 | $2,795 |
| Total Curr. Assets | $8,739 | $3,191 | $6,076 | $13,946 |
| Property Plant & Equip (Net) | $72 | $482 | $521 | $560 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $1,771 | $0 |
| Total NC Assets | $72 | $482 | $2,292 | $560 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $8,811 | $3,673 | $8,368 | $14,506 |
| Liabilities | – | – | – | – |
| Payables | $1,845 | $1,832 | $1,009 | $1,974 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $801 | $2,879 | $2,966 | $2,274 |
| Total Curr. Liab. | $2,646 | $4,711 | $3,975 | $4,248 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $704 | $4,457 | $4,050 | $5,700 |
| Total NC Liab. | $704 | $4,457 | $4,050 | $5,700 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $3,350 | $9,168 | $8,025 | $9,948 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $333 | $333 | $333 |
| Common Stock | $26 | $0 | $0 | $11 |
| Retained Earnings | -$442,152 | -$434,428 | -$424,755 | -$418,448 |
| AOCI | $0 | -$0 | -$0 | $0 |
| Other Equity | $447,587 | $428,586 | $424,753 | $422,662 |
| Total Equity | $5,461 | -$5,495 | $343 | $4,558 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $8,811 | $3,673 | $8,368 | $14,506 |
| Net Debt | -$8,086 | -$2,196 | -$6,076 | -$11,151 |